VHCP MANAGEMENT III, LLC
Latest 13F filing data - Q4 2019
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | MIST | 2.07M | $33.09M |
 | MRSN | 1.56M | $8.95M |
 | AXSM | 1.55M | $160.00M |
 | ETNB | 959K | $25.21M |
 | ADVM | 946K | $10.90M |
 | RLMD | 768K | $29.95M |
 | KALV | 620K | $11.04M |
 | TXG | 300K | $22.88M |
 | NXTC | 120K | $6.74M |
 | PTGX | 81K | $571.00K |
Milestone Pharmaceuticals Inc.
MIST
Shares Held
2.07M
Value
$33.09M
Mersana Therapeutics, Inc.
MRSN
Shares Held
1.56M
Value
$8.95M
Axsome Therapeutics, Inc.
AXSM
Shares Held
1.55M
Value
$160.00M
89bio, Inc.
ETNB
Shares Held
959K
Value
$25.21M
Adverum Biotechnologies, Inc.
ADVM
Shares Held
946K
Value
$10.90M
Relmada Therapeutics, Inc.
RLMD
Shares Held
768K
Value
$29.95M
KalVista Pharmaceuticals, Inc.
KALV
Shares Held
620K
Value
$11.04M
10x Genomics, Inc.
TXG
Shares Held
300K
Value
$22.88M
NextCure, Inc.
NXTC
Shares Held
120K
Value
$6.74M
Protagonist Therapeutics, Inc.
PTGX
Shares Held
81K
Value
$571.00K